Evidence map›Paper›PMID 32368535›Full record

ArticleWorld journal of clinical cases2020

Clinicopathological differences and correlations between right and left colon cancer.

Ioannis Kalantzis, Afroditi Nonni, Kitty Pavlakis, Eumorphia-Maria Delicha, Konstantinos Miltiadou, Christos Kosmas, Nikolaos Ziras, Konstantinos Gkoumas, Harikleia Gakiopoulou

Open access · diamondAbstract read
In one paragraph

Article in World journal of clinical cases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. The Power of MUC2 in Mucinous Adenocarcinomas.Pathobiology : journal of immunopathology, molecular and cellular biology · 2026
    Review
  3. Article
  4. Embryonic Signaling Pathways Shape Colorectal Cancer Subtypes: Linking Gut Development to Tumor Biology.Pathophysiology : the official journal of the International Society for Pathophysiology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. [Clinical and histopathological characteristics of malignant colon tumors by location].Revista medica del Instituto Mexicano del Seguro Social · 2023
    Observational
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Cytotoxic T-lymphocyte Antigen-4 (In vivo (Athens, Greece)
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Ioannis KalantzisDepartment of Gastroenterology, Korgialenio-Mpenakeio Hellenic Red Cross Hospital, Athens 11526, Greece.
Afroditi NonniFirst Department of Pathology, National and Kapodistrian University of Athens, Medical School, Athens 11527, Greece.
Kitty PavlakisFirst Department of Pathology, National and Kapodistrian University of Athens, Medical School, Athens 11527, Greece.
Eumorphia-Maria DelichaIndependent Biostatistical Consultant, ASTAT, Statistics in Clinical Research, Glyfada 16675, Greece.
Konstantinos MiltiadouHepatogastroenterology Unit, Second Department of Internal Medicine, Attikon University General Hospital, Athens 12462, Greece.
Christos KosmasDepartment of Oncology, Metaxa Anticancer Hospital, Piraeus 18537, Greece.
Nikolaos ZirasDepartment of Oncology, Metaxa Anticancer Hospital, Piraeus 18537, Greece.
Konstantinos GkoumasDepartment of Gastroenterology, Korgialenio-Mpenakeio Hellenic Red Cross Hospital, Athens 11526, Greece.
Harikleia GakiopoulouFirst Department of Pathology, National and Kapodistrian University of Athens, Medical School, Athens 11527, Greece.
Hellenic Statistical Authority · GRMetaxa Hospital · GRRed Cross Hospital · GRHellenic Red Cross · GRNational and Kapodistrian University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe differences in histopathology and molecular biology between right colon cancer (RCC) and left colon cancer (LCC) were first reported in the literature by Bufill in 1990. Since then, a large number of studies have confirmed their differences in epidemiology, clinical presentation, comorbidities and biological behaviours, which may be related to the difference in prognosis and overall survival (OS) between the two groups.

aimTo investigate statistically significant differences between Greek patients with LCC and RCC.

methodsThe present observational study included 144 patients diagnosed with colon cancer of any stage who received chemotherapy in a Greek tertiary oncology hospital during a 2.5-year period. Clinical information, comorbidities, histopathologic characteristics and molecular biomarkers were collected from the patients' medical records retrospectively, while administered chemotherapy regimens, targeted agents, progression-free survival (PFS) periods with first- and second-line chemotherapy and OS were recorded retroactively and prospectively. Data analysis was performed with the SPSS statistical package.

resultsEighty-six males and 58 females participated in the study. One hundred (69.4%) patients had a primary lesion in the left colon, and 44 (30.6%) patients had a primary lesion in the right colon. Patients with RCC were more likely to display anaemia than patients with LCC [odds ratio (OR) = 3.09], while LCC patients were more likely to develop rectal bleeding (OR = 3.37) and a feeling of incomplete evacuation (OR = 2.78) than RCC patients. Considering comorbidities, RCC patients were more likely to suffer from diabetes (OR = 3.31) and coronary artery disease (

conclusionRCC patients present more comorbidities, worse histological and molecular characteristics and a consequently higher probability of tumour recurrence, poor response to targeted therapy and shorter OS than LCC patients.

Indexed as

Colorectal neoplasmEpidermal growth factorHistologyMetabolic syndromeMolecular biologyVascular endothelial growth factor

Identifiers

PMID32368535
PMCPMC7190956
OpenAlexW3019049169

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.